Chilton Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4K Hold
37
﹤0.01% 435
2026
Q1
$17.5K Buy
37
+17
+85% +$8.56K ﹤0.01% 427
2025
Q4
$9.34K Buy
20
+2
+11% +$929 ﹤0.01% 469
2025
Q3
$7.67K Hold
18
﹤0.01% 506
2025
Q2
$6.9K Hold
18
﹤0.01% 480
2025
Q1
$6.22K Sell
18
-17
-49% -$5.47K ﹤0.01% 480
2024
Q4
$10.5K Sell
35
-21
-38% -$7.34K ﹤0.01% 453
2024
Q3
$22.8K Sell
56
-19
-25% -$6.96K ﹤0.01% 420
2024
Q2
$24.1K Buy
75
+57
+317% +$18.5K ﹤0.01% 429
2024
Q1
$6K Sell
18
-18
-50% -$5.5K ﹤0.01% 503
2023
Q4
$9.74K Buy
36
+18
+100% +$4.45K ﹤0.01% 476
2023
Q3
$4.43K Hold
18
﹤0.01% 466
2023
Q2
$5.46K Hold
18
﹤0.01% 478
2023
Q1
$4.75K Buy
+18
New +$4.57K ﹤0.01% 495
2022
Q3
Sell
-18
Closed -$3K 379
2022
Q2
$3K Buy
+18
New +$3.87K ﹤0.01% 571
2022
Q1
Sell
-189
Closed -$49K 379
2021
Q4
$49K Buy
+189
New +$46.2K ﹤0.01% 336

Other funds holding HCA

Chilton Capital Management's HCA Position: Q2 2026 in Review

Chilton Capital Management held its HCA Healthcare (HCA) position steady in Q2 2026 at 37 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #435.

Chilton Capital Management first reported a position in HCA in Q4 2021 and has held it in 16 quarters since. The position peaked at $49K in Q4 2021. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Chilton Capital Management held 37 shares of HCA Healthcare worth $14.4K as of Q2 2026.
  • Chilton Capital Management left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up ﹤0.01% of Chilton Capital Management's portfolio in Q2 2026, its #435 holding.
  • Chilton Capital Management first reported a position in HCA Healthcare in Q4 2021 and has held it in 16 quarters since.
  • Chilton Capital Management's HCA Healthcare position peaked at $49K in Q4 2021.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.